Glycos, Solix aim to make bio-isoprene from algae

ERJ staff report (DS)

Houston, Texas -- Glycos Biotechnologies, Inc. (GlycosBio) and Solix BioSystems, Inc. (Solix) said a range of experimental processes have demonstrated the potential for Solix's algae oil to be converted into a range of valuable speciality chemicals through GlycosBio's suite of proprietary biocatalysts. GlycosBio has a specific interest in synthetic rubber intermediates including bio-derived isoprene.

Solix's crude algal oil was found to be non-toxic and easily metabolised and upgraded by GlycosBio's proprietary biocatalysts. Based on the successful production of ethanol from the oil, additional studies are planned to convert the oil to other higher value chemicals. The tests were conducted at GlycosBio's research facilities in Houston and led by Dr. Daniel J. Monticello, the company's Vice President of Research and Development.

This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.

Press release from Glycos Biotechnologies